Feedback
We welcome your feedback, which will help improve this site.
Feedback form
18 September 2020
The NIHR is supporting REMAP-CAP; a nationally-prioritised study which aims to provide answers about the best treatment options for COVID-19 patients who develop pneumonia.
18 September 2020
Since 2016 the GenOMICC study has been researching what genetic factors affect whether people become severely ill from an infection. With the help of the NIHR, the study has rapidly ramped up to investigate coronavirus infection, studying genes from hundreds of very unwell patients to help understand what treatments might help tackle COVID-19.
18 September 2020
The REALIST trial is offering an innovative cell therapy treatment for patients with acute respiratory failure caused by COVID-19.
18 September 2020
The NIHR-supported RECOVERY trial is leading the way in identifying treatments for this new infectious disease.
18 September 2020
The PRINCIPLE trial is the first to test potential treatments for COVID-19 through GP surgeries.
18 September 2020
An NIHR-funded and supported trial is seeking to resolve internationally conflicting guidance about respiratory support for severely ill COVID-19 patients. By collating vital evidence, in a robust way, this trial aims to determine which method of non-invasive respiratory support may have the best outcomes for patients, reduce the need for mechanical ventilation and decrease the burden on critical care wards.
17 September 2020
The MOAM trial is the first ever large-scale trial of treatment for offenders with antisocial personality disorder. It provides an excellent demonstration of the impact of patient and public involvement in research.
15 September 2020
Manu Shankar-Hari, NIHR Clinician Scientist in Intensive Care Medicine, has been instrumental in a number of COVID-19 research projects.
14 September 2020
NIHR trial finds that a single dose of preventative prophylactic antibiotics, halves the risk of infection for women who have assisted vaginal births.
11 September 2020
A dramatic 800 calorie a day diet that has been shown to reverse diabetes is currently being piloted in the NHS across England. This follows a successful NIHR-funded trial that showed the effectiveness of the liquid diet and a larger trial into how the diet could be rolled out into everyday practice.
02 September 2020
Christine Comer was entering the third year of her NIHR Clinical Lectureship when the COVID-19 pandemic hit. Find out about her experience and how she has found returning to her research role.
17 August 2020
A quick bedside test can deliver diagnosis of respiratory virus infection in children and allow clinicians to treat patients while protecting others from infection. Results from recent trials could change care pathways in the future.
04 August 2020
It is possible to reduce the number of pneumococcal vaccines given to babies and children without increasing their risk of serious and fatal infections. An NIHR-funded trial demonstrated that fewer injections can deliver immunity in the UK, leading to the government changing the pneumococcal vaccine schedule from three doses to two.
31 July 2020
Being partway through a PhD in prison telemedicine meant public health specialist Chantal Edge was perfectly placed to lead a national rollout of telemedicine across English secure sites as a result of the COVID-19 pandemic.
29 July 2020
Healthcare workers from black, Asian and minority ethnic (BAME) backgrounds are putting their own health at risk to care for patients with COVID-19. But new research funded by the NIHR and UKRI, part of a multimillion package of new projects on COVID-19 and ethnicity, aims to understand that risk and provide evidence to inform the response to the pandemic.
16 July 2020
"The advancement of a treatment for Duchenne patients amenable to exon 53 skipping was made possible through excellent collaboration with GOSH’s BRC and CRF, Prof. Francesco Muntoni and the esteemed SKIP-NMD consortium members."
14 July 2020
“It has been one of the most busy and challenging times of my career. It has also been the most rewarding.”
23 June 2020
Phil was hospitalised with COVID-19 in early April 2020. Struggling to breathe, he was grateful to have the chance to take part in the RECOVERY-RS trial and hoped he’d be able to help other people as a result. While recovering at home but still feeling the effects of the virus, he told us his story.
18 June 2020
Following recruitment success in hospitals, Synairgen’s clinical trial of a new inhaled treatment for coronavirus infection turns its attention to COVID-19 patients in the community.
20 May 2020
Watch a representative from Microcurrent Site UK describe how the NIHR supported this small MedTech company to design, plan, set-up and deliver a clinical study.
12 May 2020
A man who beat coronavirus and was among the first patients to enrol on the NIHR-supported RECOVERY trial, has spoken of how he wanted to “step up” to help with research into treatments for the disease.
29 April 2020
A 20 minute measurement test for Attention Deficit Hyperactivity Disorder (ADHD) has transformed the experience of patients and clinicians across the East Midlands and is being rolled out across the country.
29 March 2020
Versus Arthritis has successfully collaborated with the NIHR across a range of research funding and delivery activities, from understanding the landscape in arthritis research to setting up an expert network to drive translational research in musculoskeletal diseases.
04 February 2020
Find out how NIHR support gave global pharmaceutical company, GlaxoSmithKline (GSK), the confidence to bring care home research to the UK.
31 January 2020
The NIHR Trauma Management MedTech Co-operative has collaborated with Cerebrotech Medical Systems in the evaluation of the Cerebrotech Visor, a non-invasive device which enables real-time assessment of the brain’s status following strokes and other brain injury.